{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:26:36Z","timestamp":1790061996787,"version":"4.0.1"},"reference-count":26,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s441009","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T01:50:10Z","timestamp":1702432210000},"page":"3867-3875","source":"Crossref","is-referenced-by-count":10,"title":["The Phase 3 INVIGORATE Trial of Reproxalap in Patients with Seasonal Allergic Conjunctivitis"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Christopher","family":"Starr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-1457","authenticated-orcid":true,"given":"Kelly","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3399-4673","authenticated-orcid":true,"given":"Todd","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/bj20111752","volume":"442","author":"Higdon","year":"2012","journal-title":"Biochem J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.exer.2007.09.010","volume":"86","author":"Kalariya","year":"2008","journal-title":"Exp Eye Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2012.05.005","volume":"147","author":"Kauppinen","year":"2012","journal-title":"Immunol Lett"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1006\/bcmd.1999.0234","volume":"25","author":"Mat\u00e9s","year":"1999","journal-title":"Blood Cells Mol Dis"},{"key":"ref5","first-page":"2465","volume":"16","author":"Wakamatsu","year":"2010","journal-title":"Mol Vis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/2040622315612745","volume":"7","author":"Ackerman","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2021.04.023","volume":"230","author":"Clark","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/opth.S345324","volume":"16","author":"Clark","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s40123-022-00520-z","volume":"11","author":"Cavanagh","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1089\/jop.2020.0056","volume":"36","author":"Mandell","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/jop.2020.0087","volume":"37","author":"Clark","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajo.2021.01.011","volume":"226","author":"Clark","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jaci.2010.06.050","volume":"126","author":"Singh","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/cea.12536","volume":"45","author":"Leonardi","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2147\/opth.S83263","volume":"9","author":"Torkildsen","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1034\/j.1600-0420.2000.078s230018.x","volume":"230","author":"Leonardi","year":"2000","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1398-9995.1996.tb04562.x","volume":"51","author":"R\u00f8nborg","year":"1996","journal-title":"Allergy"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/OPX.0b013e318157ac9e","volume":"84","author":"Schulze","year":"2007","journal-title":"Optom Vis Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v050.i12","volume":"50","author":"Noguchi","year":"2012","journal-title":"J Statistical Software"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.anai.2012.01.006","volume":"108","author":"Hom","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/biom11101401","volume":"11","author":"Hellenthal","year":"2021","journal-title":"Biomolecules"},{"key":"ref23","first-page":"59","volume":"240","author":"Guivernau","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.2147\/opth.S327691","volume":"15","author":"McMullin","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"ref25","unstructured":"US Food and Drug Administration. FDA Adverse Event Reporting System (FAERS). US Food and Drug Administration. Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-adverse-event-reporting-system-faers. Accessed October 7, 2023."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/all.13133","volume":"72","author":"Pfaar","year":"2017","journal-title":"Allergy"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=95223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=95223","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T01:50:14Z","timestamp":1702432214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-phase-3-invigorate-trial-of-reproxalap-in-patients-with-seasonal-a-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2147\/opth.s441009","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12]]}}}